USPTO serial 79308218
IDSIQ
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 24, 2022
- Examiner
- MESSICK, TABITHA LEE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with IDSIQ?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mary Margaret L. O'Donnell
Mary Margaret L. O'Donnell Blue Filament Law PLLC700 E. Maple RoadSuite 450Birmingham, MI 48009Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable electronic publications in the nature of newsletters and test results in the nature of test results documents and test result forms the field of medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients | ACTIVE | — |
| 016 | Printed matter in the nature of newsletters and brochures in the field of medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients | ACTIVE | — |
| 041 | Multimedia publication of printed matter in the nature of newsletters, brochures, and test results in the nature of test results documents and test result forms in the field of medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients; multimedia publication of printed matter in the nature of books, magazines and journals in the field of tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients | ACTIVE | — |
| 042 | Scientific research and development, namely pharmaceutical testing and medical testing services not for diagnostic or treatment purposes and development of pharmaceutical and medical tests, all which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients; scientific research, namely analysis of objective data on patients that was acquired by means of diagnostic tests in the context of drug administration, analysis of subjective data on patients that was acquired by means of patient questioning, analysis of such data with the aim of optimizing drug treatments and drug administration | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Idorsia Pharmaceuticals Ltd
- Other trademarks owned by Idorsia Pharmaceuticals Ltd
- Other trademarks owned by Idorsia Pharmaceuticals Ltd
- Other trademarks in Class 009
- Other trademarks in Class 016
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named IDSIQ
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 24, 2026 | RHRD | RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED | — |
| Oct 2, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 9, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 9, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 24, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 24, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 24, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 1, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 1, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 28, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 9, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 9, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 9, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 24, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 24, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 24, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 24, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 24, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 5, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 5, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 5, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 5, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 5, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 5, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jan 5, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 5, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 5, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 15, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 26, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 26, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 15, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 14, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 3, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 13, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 9, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 8, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |